{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpodcasts.prevmedhealth.com%2Fepisodes%2Faspirin-omega-3s-in-2018-ascend-aspree-trials-OVXzpz1m","width":444,"version":"1.0","type":"rich","title":"Aspirin & Omega 3s in 2018: ASCEND & ASPREE Trials","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/3512c98c-c29a-485f-8f25-7fec2feffd3f/37001a9e-d30d-417f-8f92-ec9cc19e1a22/aspirin-omega-3s-in-2018.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/63036091-b31e-4e8a-921a-ef37d06f321a\" height=\"200\" width=\"100%\" title=\"Aspirin &amp; Omega 3s in 2018: ASCEND &amp; ASPREE Trials\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"The ASCEND and ASPREE trials have thrown us a lot of curves. At the end of the day, I think we won't hear many recommendations in the future for aspirin for CV prevention. And the docs that never recommended omega 3s are all saying, \"I told you so\" regarding omega 3s.\" But not so fast. I don't think the story is over just yet."}